Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund lessened its holdings in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 22.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 94,545 shares of the software maker’s stock after selling 26,679 shares during the quarter. New York State Common Retirement Fund’s holdings in Allscripts Healthcare Solutions were worth $1,264,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. JPMorgan Chase & Co. grew its stake in Allscripts Healthcare Solutions by 23.7% during the 2nd quarter. JPMorgan Chase & Co. now owns 3,636,410 shares of the software maker’s stock valued at $67,310,000 after purchasing an additional 697,012 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Allscripts Healthcare Solutions by 30.6% during the 2nd quarter. Goldman Sachs Group Inc. now owns 3,013,235 shares of the software maker’s stock valued at $55,775,000 after purchasing an additional 705,267 shares in the last quarter. Invesco Ltd. grew its stake in Allscripts Healthcare Solutions by 12.9% during the 2nd quarter. Invesco Ltd. now owns 2,598,448 shares of the software maker’s stock valued at $48,098,000 after purchasing an additional 296,024 shares in the last quarter. SG Americas Securities LLC grew its stake in Allscripts Healthcare Solutions by 20.7% during the 3rd quarter. SG Americas Securities LLC now owns 582,533 shares of the software maker’s stock valued at $7,788,000 after purchasing an additional 99,713 shares in the last quarter. Finally, Parametric Portfolio Associates LLC grew its stake in Allscripts Healthcare Solutions by 2.0% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 473,626 shares of the software maker’s stock valued at $8,767,000 after purchasing an additional 9,512 shares in the last quarter. Hedge funds and other institutional investors own 96.40% of the company’s stock.

NASDAQ:MDRX opened at $17.88 on Friday. Allscripts Healthcare Solutions, Inc. has a 12-month low of $13.05 and a 12-month high of $19.00. The firm has a market capitalization of $2.19 billion, a P/E ratio of 3.47, a P/E/G ratio of 2.70 and a beta of 1.04. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.42 and a quick ratio of 1.42. The business has a 50 day simple moving average of $17.41 and a 200 day simple moving average of $16.22.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings data on Thursday, November 4th. The software maker reported $0.27 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.18 by $0.09. Allscripts Healthcare Solutions had a return on equity of 6.98% and a net margin of 51.74%. The business had revenue of $369.00 million during the quarter, compared to analyst estimates of $376.09 million. During the same quarter in the previous year, the firm posted $0.15 EPS. The business’s revenue for the quarter was down 8.2% compared to the same quarter last year. Research analysts anticipate that Allscripts Healthcare Solutions, Inc. will post 0.67 EPS for the current fiscal year.

Several brokerages have recently commented on MDRX. lifted their target price on Allscripts Healthcare Solutions from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Monday, November 8th. Deutsche Bank Aktiengesellschaft lifted their target price on Allscripts Healthcare Solutions from $18.00 to $20.00 and gave the stock a “hold” rating in a research report on Tuesday, November 23rd. Finally, Cantor Fitzgerald reiterated a “neutral” rating on shares of Allscripts Healthcare Solutions in a research report on Friday, November 5th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $19.17.

In other Allscripts Healthcare Solutions news, CEO Paul Black sold 60,000 shares of Allscripts Healthcare Solutions stock in a transaction on Friday, December 10th. The stock was sold at an average price of $17.68, for a total transaction of $1,060,800.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Richard J. Poulton sold 10,000 shares of Allscripts Healthcare Solutions stock in a transaction on Monday, November 15th. The shares were sold at an average price of $16.38, for a total value of $163,800.00. The disclosure for this sale can be found here. Insiders own 1.91% of the company’s stock.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc engages in the provision of clinical, financial, and operational results services. It operates through the Provider and Veradigm segment. The Provider segment includes the hospitals and health systems, ambulatory, CarePort, FollowMyHealth, EPSiTM, EISClassics, and 2bPrecise strategic business units.

Recommended Story: What is a dividend reinvestment plan?

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.